EGFR and neoplasm: EGFR is a transmembrane growth factor receptor and its downstream signaling pathways frequently contribute to tumor progression and metastasis (Ciardiello and Tortora, 2008; Kumar et al., 2016; Koustas et al., 2017; Singla et al., 2018).